Ryosuke Oki

424 total citations
27 papers, 134 citations indexed

About

Ryosuke Oki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ryosuke Oki has authored 27 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Ryosuke Oki's work include Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Ryosuke Oki is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Ryosuke Oki collaborates with scholars based in Japan and Italy. Ryosuke Oki's co-authors include Tetsuya Urasaki, Yukinori Ozaki, Ryuji Kaji, Yuishin Izumi, Takeshi Yuasa, Yuji Miura, Misa Onishi, Masato Ishigami, Hiroyasu Ueda and Hisatoyo Hiraoka and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Clinical Neurophysiology.

In The Last Decade

Ryosuke Oki

21 papers receiving 134 citations

Peers

Ryosuke Oki

ONCOL

PRM

CCM

EDM

Andrea Werner United States

Fanny Duval France

Torsten Holm Nielsen Denmark

Joanna Lim Malaysia

Íngrid Martí-Pàmies Spain

Ayça Erşen Danyeli Türkiye

Seong‐Ik Kim South Korea

Feifei Zhang China

Brandon Coder United States

Andrea Werner United States

Ryosuke Oki

53 ×1.3

ONCOL

37 ×1.1

PRM

30 ×1.0

55 ×2.2

CCM

6 ×0.3

EDM

Citations per year, relative to Ryosuke Oki Ryosuke Oki (= 1×) peers Andrea Werner

Countries citing papers authored by Ryosuke Oki

Since Specialization

Citations

This map shows the geographic impact of Ryosuke Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Oki more than expected).

Fields of papers citing papers by Ryosuke Oki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Oki. The network helps show where Ryosuke Oki may publish in the future.

Co-authorship network of co-authors of Ryosuke Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Oki. A scholar is included among the top collaborators of Ryosuke Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Oki. Ryosuke Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takamatsu, Naoko, Tomoyasu Matsubara, M Tani, et al.. (2025). Evaluation of the diagnostic performance of brachial plexus ultrasound in amyotrophic lateral sclerosis. Clinical Neurophysiology. 175. 2110741–2110741.

Fukuda, Naoki, Kazuhisa Toda, Ryosuke Oki, et al.. (2024). Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib. Endocrine Journal. 71(4). 363–371. 1 indexed citations

Yasuda, Yoshinari, Tetsuya Urasaki, Ryosuke Oki, et al.. (2024). 301P Effectiveness and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: A preliminary report of real-world data from a single institution in Japan. Annals of Oncology. 35. S1520–S1520.

Kaji, Ryuji, Yuishin Izumi, & Ryosuke Oki. (2024). Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis. Current Opinion in Neurology. 37(5). 593–602. 1 indexed citations

Urasaki, Tetsuya, Makiko Ono, Kyoko Yamashita, et al.. (2024). Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report. Oncology Letters. 29(3). 108–108.

Yasuda, Yosuke, Tetsuya Urasaki, Ryosuke Oki, et al.. (2024). Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution. International Journal of Clinical Oncology. 29(12). 1925–1930. 1 indexed citations

Ueki, Arisa, Ryosuke Oki, Tetsuya Urasaki, et al.. (2023). A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome. IJU Case Reports. 6(5). 286–289.

Fukuda, Naoki, Ryosuke Oki, Xiaofei Wang, et al.. (2023). Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck. Oncology. 101(8). 502–511. 1 indexed citations

Ohmoto, Akihiro, Kenji Nakano, Naoki Fukuda, et al.. (2023). Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. PLoS ONE. 18(3). e0280508–e0280508. 1 indexed citations

10.

Fukuda, Naoki, Kazuhisa Toda, Akihiro Ohmoto, et al.. (2022). A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients. Endocrine. 76(1). 70–77. 6 indexed citations

11.

Oki, Ryosuke, Tetsuya Urasaki, Arisa Ueki, et al.. (2022). A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome. IJU Case Reports. 6(1). 33–36. 2 indexed citations

12.

Yuasa, Takeshi, Tetsuya Urasaki, & Ryosuke Oki. (2022). Recent Advances in Medical Therapy for Urological Cancers. Frontiers in Oncology. 12. 746922–746922. 9 indexed citations

13.

Sako, Wataru, Takashi Abe, Takahiro Furukawa, et al.. (2019). Differences in the intra-cerebellar connections and graph theoretical measures between Parkinson's disease and multiple system atrophy. Journal of the Neurological Sciences. 400. 129–134. 14 indexed citations

14.

Inoshita, Naoko, Yuji Miura, Ryosuke Oki, et al.. (2018). The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis. Urologic Oncology Seminars and Original Investigations. 36(8). 365.e9–365.e14. 7 indexed citations

15.

Oki, Ryosuke, Chihiro Kondoh, Yuji Miura, et al.. (2017). S-1 plus cisplatin combination therapy in patients with urachal carcinoma: A retrospective study. Annals of Oncology. 28. x84–x84.

16.

Ozaki, Yukinori, Junichi Shindoh, Yuji Miura, et al.. (2017). Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report. BMC Cancer. 17(1). 778–778. 20 indexed citations

17.

Saji, Naoki, Toshitaka Kawarai, Ryosuke Miyamoto, et al.. (2015). Exome sequencing identifies a novel intronic mutation in ENG that causes recurrence of pulmonary arteriovenous malformations. Journal of the Neurological Sciences. 352(1-2). 29–33. 2 indexed citations

18.

Oki, Ryosuke, A Uchino, Yuishin Izumi, et al.. (2015). An autopsy case of progressive generalized muscle atrophy over 14 years due to post-polio syndrome. Rinsho Shinkeigaku. 56(1). 12–16. 2 indexed citations

19.

Kawarai, Toshitaka, Ryosuke Miyamoto, Atsuko Mori, et al.. (2015). Late-onset spastic paraplegia: Aberrant SPG11 transcripts generated by a novel splice site donor mutation. Journal of the Neurological Sciences. 359(1-2). 250–255. 6 indexed citations

20.

Yamamoto, Hiroyasu, Misa Onishi, Naoko Miyamoto, et al.. (2013). Novel Combined GPIHBP1 Mutations in a Patient with Hypertriglyceridemia Associated with CAD. Journal of Atherosclerosis and Thrombosis. 20(10). 777–784. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact